Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00654355 · ClinicalTrials.gov registry record · Phase 4
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
A Phase 4 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00654355 is a Phase 4 study that has completed, run by Wake Forest University. The registered enrollment target is 30 participants.
The verdict
NCT00654355, a Phase 4 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this research study is to better understand how the study drug works when people use it to treat atopic dermatitis.
Interventions
- DRUG tacrolimus ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00654355
The ClinicalTrials.gov registry entry for NCT00654355 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tacrolimus ointment is the first listed.
NCT00654355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00654355 about?
NCT00654355 is a clinical study titled "Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit". The purpose of this research study is to better understand how the study drug works when people use it to treat atopic dermatitis.
What is the current status of trial NCT00654355?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2008-04. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00654355?
The interventions under investigation include: tacrolimus ointment (DRUG).
Who is sponsoring clinical trial NCT00654355?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.